Zobrazeno 1 - 10
of 1 090
pro vyhledávání: '"Hans Peter Hartung"'
Autor:
Martin Vališ, Anat Achiron, Hans Peter Hartung, Jan Mareš, Veronika Tichá, Pavel Štourač, Simona Halusková, Francesco Angelucci, Zbyšek Pavelek
Publikováno v:
Drugs in R&D, Vol 23, Iss 4, Pp 331-338 (2023)
Abstract Multiple sclerosis (MS) is a chronic neurodegenerative disease that affects the central nervous system (CNS). Currently, MS treatment is limited to several Food and Drug Administration (FDA)- and European Medicines Agency (EMA)-approved medi
Externí odkaz:
https://doaj.org/article/7ae609d3e2254eba86eb7e8f90c19741
Autor:
Iria Samper Agrelo, Jessica Schira-Heinen, Felix Beyer, Janos Groh, Christine Bütermann, Veronica Estrada, Gereon Poschmann, Ana Bribian, Janusz J. Jadasz, Laura Lopez-Mascaraque, David Kremer, Rudolf Martini, Hans Werner Müller, Hans Peter Hartung, James Adjaye, Kai Stühler, Patrick Küry
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 12, p 4350 (2020)
Mesenchymal stem cell (MSC)-secreted factors have been shown to significantly promote oligodendrogenesis from cultured primary adult neural stem cells (aNSCs) and oligodendroglial precursor cells (OPCs). Revealing underlying mechanisms of how aNSCs c
Externí odkaz:
https://doaj.org/article/b99fbf60dc55459592c47522d89a65b6
Autor:
Delphine Bachelet, Signe Hässler, Cyprien Mbogning, Jenny Link, Malin Ryner, Ryan Ramanujam, Michael Auer, Poul Erik Hyldgaard Jensen, Nils Koch-Henriksen, Clemens Warnke, Kathleen Ingenhoven, Dorothea Buck, Verena Grummel, Andy Lawton, Naoimh Donnellan, Agnès Hincelin-Mery, Dan Sikkema, Marc Pallardy, Bernd Kieseier, Bernard Hemmer, Hans Peter Hartung, Per Soelberg Sorensen, Florian Deisenhammer, Pierre Dönnes, Julie Davidson, Anna Fogdell-Hahn, Philippe Broët, ABIRISK Consortium
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0162752 (2016)
Immunogenicity of biopharmaceutical products in multiple sclerosis is a frequent side effect which has a multifactorial etiology. Here we study associations between anti-drug antibody (ADA) occurrence and demographic and clinical factors. Retrospecti
Externí odkaz:
https://doaj.org/article/f42ed773756e4b9bb482310f2683d0bf
Autor:
Bruce A. C. Cree, Rachel Maddux, Amit Bar‐Or, Hans‐Peter Hartung, Amandeep Kaur, Elizabeth Brown, Yicong Li, Yanhua Hu, James K. Sheffield, Diego Silva, Sarah Harris
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 10, Iss 10, Pp 1725-1737 (2023)
Abstract Objective To investigate the serologic response, predictors of response, and clinical outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination and infection in ozanimod‐treated participants with
Externí odkaz:
https://doaj.org/article/4a8aee4d3b7d474b98f18866748e3647
Autor:
Hans-Peter Hartung, Bruce A.C. Cree, Michael Barnett, Sven G. Meuth, Amit Bar-Or, Lawrence Steinman
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Disease-modifying therapies for relapsing multiple sclerosis reduce relapse rates by suppressing peripheral immune cells but have limited efficacy in progressive forms of the disease where cells in the central nervous system play a critical role. To
Externí odkaz:
https://doaj.org/article/87bfd7c2d3e74112b55c030c71ee445b
Autor:
Arianna Di Stadio, Pietro De Luca, Nehzat Koohi, Diego Kaski, Massimo Ralli, Anja Giesemann, Hans-Peter Hartung, Marta Altieri, Daniela Messineo, Athanasia Warnecke, Teresa Frohman, Elliot M. Frohman
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundHearing can be impaired in many neurological conditions and can even represent a forme fruste of specific disorders. Auditory function can be measured by either subjective or objective tests. Objective tests are more useful in identifying w
Externí odkaz:
https://doaj.org/article/87a12e9ad7db4df98acd1d033e90a957
Autor:
Peter Göttle, Janos Groh, Laura Reiche, Joel Gruchot, Nicole Rychlik, Luisa Werner, Iria Samper Agrelo, Rainer Akkermann, Annika Zink, Alessandro Prigione, Hans-Peter Hartung, Rudolf Martini, Patrick Küry
Publikováno v:
Journal of Neuroinflammation, Vol 20, Iss 1, Pp 1-16 (2023)
Abstract Background Promotion of myelin repair in the context of demyelinating diseases such as multiple sclerosis (MS) still represents a clinical unmet need, given that this disease is not only characterized by autoimmune activities but also by imp
Externí odkaz:
https://doaj.org/article/5baca0a9509e4f5894918ed863c606fa
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/0ab245ad79d54744a7f56c45ddf98230
Autor:
Joseph R. Berger, Hans-Peter Hartung
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/3aef3971c0b2443c947d685571be9582
Autor:
Moritz J. Furman, Sven G. Meuth, Philipp Albrecht, Michael Dietrich, Heike Blum, Jan Mares, Ron Milo, Hans-Peter Hartung
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Cumulative evidence along several lines indicates that B cells play an important role in the pathological course of multiple sclerosis (MS), neuromyelitisoptica spectrum disorders (NMOSD) and related CNS diseases. This has prompted extensive research
Externí odkaz:
https://doaj.org/article/9e0e0ed8ac634010b2533b9df63f19b4